Seroprevalence of ML Flow test in leprosy contacts from State of Minas Gerais, Brazil;Soroprevalência do teste ML Flow em contatos de hanseníase de Minas Gerais

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 41, Issue SUPPL. 2, 2008, Pages 56-59

  De Andrade, Ana Regina Coelho ^a,b,e   Grossi, Maria Aparecida De Faria ^a,b   Bührer Sékula, Samira ^c,d   Antunes, Carlos Maurício Figueiredo ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Secretary of Health of the Minas Gerais State   (Brazil)

^c ROYAL TROPICAL INSTITUTE   (Netherlands)

^d FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^e NONE   (Brazil)

Author keywords

Leprosy; Leprosy epidemiology; Leprosy prevention and control; Serology

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; PHENOLIC GLYCOLIPID I;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; ASSAY; BCG VACCINATION; BRAZIL; DIAGNOSTIC TEST; DISEASE TRANSMISSION; FEMALE; HOUSEHOLD; HUMAN; INFECTION RISK; LABORATORY TEST; LATERAL FLOW ASSAY; LEPROSY; LEPROSY CONTROL; MAJOR CLINICAL STUDY; MALE; MULTIBACILLARY LEPROSY; NONHUMAN; PAUCIBACILLARY LEPROSY; SEROLOGY; SEROPREVALENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; BRAZIL; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FAMILY; FEMALE; HUMANS; INFANT; LEPROSY; MALE; MIDDLE AGED; MYCOBACTERIUM LEPRAE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEX FACTORS; YOUNG ADULT;

EID: 70349469495     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822008000700012     Document Type: Article

References (32)

1. Agis F, Schlich P, Cartel JL, Guidi C, Bach MA. Use of anti-M.leprae phenolic glycolipid-1antibody detection for early diagnosis and prognosis of leprosy. International Journal of Leprosy and Other Mycobacterial Diseases 56: 527-536, 1988.
2. Bagshawe A Garsia RJ, Baumgart K, Astbury L. IgM serum antibodies to phenolic glycolipid-1 and clinical leprosy: Two years' observation in a community with hyperendemic leprosy. International Journal of Leprosy and Other Mycobacterial Diseases 58: 25-30, 1990. (Pubitemid 20129566)
3. Bakker MI, Hatta M, Kwenang A, Faber WR, van Beers SM, Klatser PR, Oskam L. Population survey to determine risk factors for Mycobacterium leprae transmission and infection. International Journal of Epidemiology 33: 1-8, 2004.
4. Bakker MI Hatta M, Kwenang A, Van Mosseveld P, Faber WR, Klatser PR, Oskam L. Risk factors for developing leprosy - a population-based cohort study in Indonesia. Leprosy Review 77: 48-61, 2006.
5. Baumgart KW, Britton WJ, Mullins RJ, Basten A, Barnetson RS. Subclinical infection with Mycobacterium leprae - a problem for leprosy control strategies. Transactions of the Royal Society of Tropical Medicine and Hygiene 87: 412-415, 1993.
6. Brasil. Ministério da Saúde. Portaria 1073/GM de 26 de setembro de 2000. Diário Oficial da União. 188-E - página 18, Seção 1 (28 setembro 2000)
7. Brasil MTLRF, Oliveira LR, Rímoli N, Cavallari S, Gonçalves O, Lessa Z, Rotta O. Sorologia anti-PGL-1 e risco de ocorrência de hanseníase em área de alta endemicidade do Estado de São Paulo: quatro anos de seguimento. Revista Brasileira de Epidemiologia 6: 262-271, 2003.
8. Brennan PJ. Skin test development in leprosy: progress with first-generation skin test antigens, and an approch to the second generation. Workshop Proceedings Leprosy research of the new millennium, 2000 26-28 June, S 50-54 (Association Française Raoul Follereau, Paris).
9. Bührer-Sékula S, Smits HL, Gussenhoven GC, van Leeuwen J, Amador S, Fujiwara T, Klatser PR, Oskam L. Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy. Journal of Clinical Microbiology 41: 1991-1995, 2003.
10. Calado KLS, Vieira AG, Durães S, Bührer-Sékula S, Oliveira MLW. Positividade sorológica anti-PGL-I em contatos domiciliares e peridomiciliares de hanseníase em área urbana. Anais Brasileiros de Dermatologia 80: (supl 3) S 301-306, 2005. (Pubitemid 46202449)
11. Cellona RV, Walsh GP, Fajardo TTJr, Abalos RM, la Cruz EC, Guido-Villahermosa L, Felicio-Balagon MV, Steenbergen GJ, Douglas JT. Cross-Sectional assessment of ELISA reactivity in leprosy patients, contacts, and normal population using the semisynthetic antigen natural disaccharide octyl bovine serum albumin (ND-O-BSA) in Cebu, the Philippines. International Journal of Leprosy and Other Mycobacterial Diseases 61: 192-198, 1993.
12. Chanteau SP, Glaziou P, Plichart C, Luquiaud P, Plichart R, Faucher JF, Cartel JL. Low predictive value of PGL-1 serology for early diagnosis of leprosy in family contacts: Results of a 10-year prospective field study in French Polynesia. International Journal of Leprosy and Other Mycobacterial Diseases 61: 533-541, 1993. (Pubitemid 24129408)
13. Cunanan A, Chan GP, Douglas JT. Risk of development of leprosy among Culion contacts. International Journal of Leprosy and Other Mycobacterial Diseases 66: 578A, 1998.
14. Douglas JT, Cellona RV, Fajardo TTJr, Abalos RM, Balagon MV, Klatser PR. Prospective study of serological conversion as a risk factor for development of leprosy among household contacts. Clinical and Diagnostic Laboratory Immunology 11: 897-900, 2004.
15. Douglas JT, Hirsch DS, Fajardo TT, Guido LS, Klatser PR. Serological reactivity and early detection of leprosy among contacts of lepromatous patients in Cebu. International Journal of Leprosy and Other Mycobacterial Diseases 55: 718-721, 1987.
16. Fine PEM, Sterne JA, Ponnighaus JM, Bliss L, Saui J, Chihana A, Munthali M, Warndorff DK. Household and dwelling contact as risk factors for leprosy in Northern Malawi. American Journal of Epidemiology 146: 91-102,1997. (Pubitemid 27291370)
17. Fine PEM, Ponnighaus JM, Burgess P, Clarkson JA, Draper CC. Seroepidemiological studies of leprosy in northern Malawi based on an enzyme-linked immunosorbent assay using synthetic glycoconjugate antigen. International Journal of Leprosy and Other Mycobacterial Diseases 56: 243-254, 1998.
18. Gonzalez-Abreu E, Mora N, Perez M, Pereira M, Perez J, Gonzalez AB. Serodiagnosis of leprosy in patients'contacts by enzyme-linked immunosorbent assay. Leprosy Review 61: 145-150, 1990. (Pubitemid 20293821)
19. Hatta M, van Beers SM, Madjid B, Djumadi A, de Wit MY, Klatser PR. Distribution and persistence of Mycobacterium leprae nasal carriage among a population in which leprosy is endemic in Indonesia. Transactions of the Royal Society of Tropical Medicine and Hygiene 89: 381-385, 1995.
20. Hussain R, Jamil S, Kifayet A, Firdausi F, Dockrell HM, Lucas S, Hasan R. Quantitation of IgM antibodies to the M. leprae synthetic dissacharide can predict early bacterial multiplication in leprosy. International Journal of Leprosy and Other Mycobacterial Diseases 58: 491-502, 1990.
21. Jain S, Reddy RG, Osmani SN, Lockwood DN, Suneetha S. Childhood leprosy in an urban clinic, Hyderabad, Índia: clinical presentation and the role of household contacts. Leprosy Review 73: 248-253, 2002.
22. Klatser PR. Use of a Mycobacterium leprae dipstick to classify patients with leprosy. Workshop Proceedings Leprosy research of the new millennium 2000 26-28 June, S 67-72 (Association Française Raoul Follereau, Paris).
23. Menzel S, Harboe M, Bergsvik H, Brennan PJ. Antibodies to a synthetc analog of phenolic glycolipid-1 of Mycobacterium leprae in healthy household contacts of patients with leprosy. International Journal of Leprosy and Other Mycobacterial Diseases 55: 617-625, 1987.
24. Moet FJ, Oskam L, Faber R, Pahan D, Richardus JH. A study on transmission and a trial of chemoprophylaxis in contacts of leprosy patients: design, methodology and recruitment findings of COLEP. Leprosy Review 75:376-388, 2004.
25. Oskam L, Slim E, Bührer-Sékula S. Serology:recente developments, strengths, limitations and prospects:a state of the art overview. Leprosy Review 74: 196-205, 2003. (Pubitemid 37205454)
26. Sinha S, Kannan S, Nagaraju B, Sengupta U, Gupte MD Utility of serodiagnostic tests for leprosy: a study in an endemic population in South India. Leprosy Review, 75: 266-273, 2004,
27. Smith CM and Smith WCS. Chemoprophylaxs is effective in the prevention of leprosy in endemic countries: a systematic review and meta-analysis. Journal of Infection 41: 137-142, 2000.
28. Soebono H, Klatser P. A seroepidemiological stdy of leprosy in high and low-endemic indonesian villages. International Journal of Leprosy and Other Mycobacterial Diseases s 59: 416-425, 1991.
29. Ulrich M, Smith PG, Sampson C, Zuniga M, Centeno M, Garcia V, Manrique X, Salgado A, Convit J. IgM antibodies to native phenolic glycolipid 1 in contacts of leprosy patients in Venezuela. International Journal of Leprosy and Other Mycobacterial Diseases 59: 405-415, 1991.
30. Van Beers SM, Izumi S, Madjid B, Maeda Y, Day R, Klatser PR. An epidemiological study of leprosy infection by serology and polymerase chain reaction. International Journal of Leprosy and Other Mycobacterial Diseases 62: 1-9, 1994. (Pubitemid 24297753)
31. Van Beers SM, Hatta M, Klatser PR. Seroprevalence rates of antibodies to phenolic glycolipd-1 among school children as an indicator of leprosy endemicity. International Journal of Leprosy and Other Mycobacterial Diseases 67: 243-249, 1999. (Pubitemid 29536454)
32. Van Beers SM, De Wit MYL, Klatser PR. The epidemiology of Mycobacterium leprae: Recent insight. FEMS Microbiology Letters136: 221-230, 1996.